Jeffrey Rae Gingrich | Scholars@Duke

Jeffrey Rae Gingrich
Professor of Surgery

Current Research Interests

Basic and translational research in urologic malignancies, particularly bladder cancer and some work in benign urologic conditions. I also have an interest in global health.

Current Appointments & Affiliations

Professor of Surgery, Surgery, Urology, Surgery 2018

Contact Information

DUMC 3707, Durham, NC 27710
DUMC 3707, Durham, NC 27710
jeffrey.gingrich@duke.edu (919) 681-8760

Background
Education, Training, & Certifications
- PostDoc Fellow Urology/Cell Biology, Surgery, Baylor College of Medicine 1994 - 1997
- Urologic Surgery Resident, Surgery, Duke University 1990 - 1994
- Urologic Surgery Fellow, Surgery, Duke University 1989 - 1990
- General Surgery Intern, Surgery, University of Michigan, Ann Arbor 1987 - 1989
- M.D., University of Michigan, Ann Arbor 1987
- B.A., Spring Arbor University 1983
Medical Licensure
- 421293. Pennsylvania. 2003
- 33828. North Carolina. 1991
Duke Appointment History
- Instructor in the Department of Surgery, Surgery, Urology, Surgery 2018
Academic Positions Outside Duke
- Associate Professor Urology, University of Pittsburgh. 2003 - 2018
- Associate Professor of Urology, University of Tennessee. 2001 - 2003
- Assistant Professor of Urology, University of Tennessee. 1997 - 2001
Publications & Artistic Works
Selected Publications
- Academic Articles
  - Grajales, Valentina, Jathin Bandari, Nathan E. Hale, Jonathan G. Yabes, Robert M. Turner, Mina M. Fam, Lindsay M. Sabik, Jeffrey R. Gingrich, Benjamin J. Davies, and Bruce L. Jacobs. “Associations Between Female Sex and Treatment Patterns and Outcomes for Muscle-invasive Bladder Cancer.” Urology, July 14, 2020. https://doi.org/10.1016/j.urology.2020.06.058.
    Full Text Link to Item
  - Macleod, Liam C., Mina M. Fam, Jonathan G. Yabes, Nathan E. Hale, Robert M. Turner, Samia H. Lopa, Jeffrey R. Gingrich, et al. “Comparison of Neoadjuvant and Adjuvant Chemotherapy in Muscle-invasive Bladder Cancer.” Clin Genitourin Cancer 18, no. 3 (June 2020): 201-209.e2. https://doi.org/10.1016/j.clgc.2019.12.011.
    Full Text Link to Item
  - Inouye, Brian M., and Jeffrey R. Gingrich. “EDITORIAL COMMENT.” Urology 136 (February 2020): 249. https://doi.org/10.1016/j.urology.2019.09.060.
    Full Text Link to Item
  - VanDusen, Keith W., Sarada Eleswarpu, Eugene W. Moretti, Michael J. Devinney, Donna M. Crabtree, Daniel T. Laskowitz, Marty G. Woldorff, et al. “The MARBLE Study Protocol: Modulating ApoE Signaling to Reduce Brain Inflammation, DeLirium, and PostopErative Cognitive Dysfunction.” J Alzheimers Dis 75, no. 4 (2020): 1319–28. https://doi.org/10.3233/JAD-191185.
    Full Text Open Access Copy Link to Item
  - Hale, Nathan E., Liam C. Macleod, Jonathan G. Yabes, Robert M. Turner, Mina M. Fam, Jeffrey R. Gingrich, Ted A. Skolarus, et al. “Implications of Cystectomy Travel Distance for Hospital Readmission and Survival.” Clin Genitourin Cancer 17, no. 6 (December 2019): e1171–80. https://doi.org/10.1016/j.clgc.2019.08.005.
    Full Text Link to Item
  - Li, Feng, Laura E. Pascal, Donna B. Stolz, Ke Wang, Yibin Zhou, Wei Chen, Yadong Xu, et al. “E-cadherin is downregulated in benign prostatic hyperplasia and required for tight junction formation and permeability barrier in the prostatic epithelial cell monolayer.” Prostate 79, no. 11 (August 2019): 1226–37. https://doi.org/10.1002/pros.23806.
    Full Text Link to Item
  - Macleod, Liam C., Jonathan G. Yabes, Michelle Yu, Mina M. Fam, Nathan E. Hale, Robert M. Turner, Samia H. Lopa, et al. “Trends and appropriateness of perioperative chemotherapy for muscle-invasive bladder cancer.” Urol Oncol 37, no. 7 (July 2019): 462–69. https://doi.org/10.1016/j.urolonc.2019.04.006.
    Full Text Link to Item
  - Skolarus, Ted A., Tabitha Metreger, Daniela Wittmann, Soohyun Hwang, Hyungjin Myra Kim, Robert L. Grubb, Jeffrey R. Gingrich, Hui Zhu, John D. Piette, and Sarah T. Hawley. “Self-Management in Long-Term Prostate Cancer Survivors: A Randomized, Controlled Trial.” J Clin Oncol 37, no. 15 (May 20, 2019): 1326–35. https://doi.org/10.1200/JCO.18.01770.
    Full Text Link to Item
  - Morgan, Tara Nikonow, Robert M. Turner, Julian Baptiste, Timothy D. Lyon, Jodi K. Maranchie, Ronald L. Hrebinko, Benjamin J. Davies, Jeffrey R. Gingrich, and Bruce L. Jacobs. “Small cell bladder cancer: should we consider prophylactic cranial irradiation?” Int Braz J Urol 45, no. 2 (March 2019): 299–305. https://doi.org/10.1590/S1677-5538.IBJU.2018.0242.
    Full Text Link to Item
  - Lee, Austin J., Jonathan G. Yabes, Nathan Hale, Ronald L. Hrebinko, Jeffrey R. Gingrich, Jodi K. Maranchie, Mina M. Fam, et al. “The comparative effectiveness of quadratus lumborum blocks and paravertebral blocks in radical cystectomy patients.” Can J Urol 25, no. 2 (April 2018): 9255-9261.
    Link to Item
  - Maganty, Avinash, Anisleidy Fombona, Jathin Bandari, Timothy D. Lyon, Scott Kulich, Jeffrey R. Gingrich, Joel D. Bigley, and Tatum V. Tarin. “Aggressive surgical management of adenocarcinoma of the rete testis.” Urol Case Rep 16 (January 2018): 72–74. https://doi.org/10.1016/j.eucr.2017.10.001.
    Full Text Link to Item
  - Tyagi, Pradeep, Saundra S. Motley, Tatsuki Koyama, Mahendra Kashyap, Jeffrey Gingrich, Naoki Yoshimura, and Jay H. Fowke. “Molecular correlates in urine for the obesity and prostatic inflammation of BPH/LUTS patients.” Prostate 78, no. 1 (January 2018): 17–24. https://doi.org/10.1002/pros.23439.
    Full Text Link to Item
  - Lyon, Timothy D., Robert M. Turner I I, Dawn McBride, Li Wang, Jeffrey R. Gingrich, Ronald L. Hrebinko, Bruce L. Jacobs, Benjamin J. Davies, and Tatum V. Tarin. “Preoperative immunonutrition prior to radical cystectomy: a pilot study.” Can J Urol 24, no. 4 (August 2017): 8895–8901.
    Link to Item
  - Skolarus, Ted A., Tabitha Metreger, Soohyun Hwang, Hyungjin Myra Kim, Robert L. Grubb, Jeffrey R. Gingrich, and Sarah T. Hawley. “Optimizing veteran-centered prostate cancer survivorship care: study protocol for a randomized controlled trial.” Trials 18, no. 1 (April 18, 2017): 181. https://doi.org/10.1186/s13063-017-1925-4.
    Full Text Link to Item
  - Tyagi, Pradeep, Saundra S. Motley, Mahendra Kashyap, Subrata Pore, Jeffrey Gingrich, Zhou Wang, Naoki Yoshimura, and Jay H. Fowke. “Urine chemokines indicate pathogenic association of obesity with BPH/LUTS.” Int Urol Nephrol 47, no. 7 (July 2015): 1051–58. https://doi.org/10.1007/s11255-015-0992-2.
    Full Text Link to Item
  - Pascal, Laura E., Khalid Z. Masoodi, Katherine J. O’Malley, Daniel Shevrin, Jeffrey R. Gingrich, Rahul A. Parikh, and Zhou Wang. “5α-Reductase inhibition coupled with short off cycles increases survival in the LNCaP xenograft prostate tumor model on intermittent androgen deprivation therapy.” J Urol 193, no. 4 (April 2015): 1388–93. https://doi.org/10.1016/j.juro.2014.10.101.
    Full Text Link to Item
  - Funahashi, Yasuhito, Zhou Wang, Katherine J. O’Malley, Pradeep Tyagi, Donald B. DeFranco, Jeffrey R. Gingrich, Ryosuke Takahashi, Tsuyoshi Majima, Momokazu Gotoh, and Naoki Yoshimura. “Influence of E. coli-induced prostatic inflammation on expression of androgen-responsive genes and transforming growth factor beta 1 cascade genes in rats.” Prostate 75, no. 4 (March 1, 2015): 381–89. https://doi.org/10.1002/pros.22924.
    Full Text Link to Item
  - Correa, Andres F., Katherine Theisen, Matthew Ferroni, Jodi K. Maranchie, Ronald Hrebinko, Benjamin J. Davies, and Jeffrey R. Gingrich. “The Role of Interferon in the Management of BCG Refractory Nonmuscle Invasive Bladder Cancer.” Adv Urol 2015 (2015): 656918. https://doi.org/10.1155/2015/656918.
    Full Text Link to Item
  - Kalinski, Pawel, and Jeffrey R. Gingrich. “Toward improved effectiveness of bladder cancer immunotherapy.” Immunotherapy 7, no. 10 (2015): 1039–42. https://doi.org/10.2217/imt.15.71.
    Full Text Link to Item
  - Kashyap, Mahendra, Subrata Pore, Zhou Wang, Jeffrey Gingrich, Naoki Yoshimura, and Pradeep Tyagi. “Inflammasomes are important mediators of prostatic inflammation associated with BPH.” J Inflamm (Lond) 12 (2015): 37. https://doi.org/10.1186/s12950-015-0082-3.
    Full Text Link to Item
  - Lyon, Timothy D., Nicholas J. Farber, Leo C. Chen, Thomas W. Fuller, Benjamin J. Davies, Jeffrey R. Gingrich, Ronald L. Hrebinko, Jodi K. Maranchie, Jennifer M. Taylor, and Tatum V. Tarin. “Total Psoas Area Predicts Complications following Radical Cystectomy.” Adv Urol 2015 (2015): 901851. https://doi.org/10.1155/2015/901851.
    Full Text Link to Item
  - Muthuswamy, Ravikumar, Liwen Wang, Jamie Pitteroff, Jeffrey R. Gingrich, and Pawel Kalinski. “Combination of IFNα and poly-I:C reprograms bladder cancer microenvironment for enhanced CTL attraction.” J Immunother Cancer 3 (2015): 6. https://doi.org/10.1186/s40425-015-0050-8.
    Full Text Link to Item
  - Cancer Genome Atlas Research Network, Paul S. “Comprehensive molecular characterization of urothelial bladder carcinoma.” Nature 507, no. 7492 (March 20, 2014): 315–22. https://doi.org/10.1038/nature12965.
    Full Text Link to Item
  - Armstrong, A. J., M. Häggman, W. M. Stadler, J. R. Gingrich, V. Assikis, J. Polikoff, J. E. Damber, et al. “Long-term survival and biomarker correlates of tasquinimod efficacy in a multicenter randomized study of men with minimally symptomatic metastatic castration-resistant prostate cancer.” Clin Cancer Res 19, no. 24 (December 15, 2013): 6891–6901. https://doi.org/10.1158/1078-0432.CCR-13-1581.
    Full Text Link to Item
  - Lotan, Yair, Gilad Amiel, Stephen A. Boorjian, Peter E. Clark, Michael Droller, Jeffrey R. Gingrich, Thomas J. Guzzo, et al. “Comprehensive handbook for developing a bladder cancer cystectomy database.” Urol Oncol 31, no. 6 (August 2013): 812–26. https://doi.org/10.1016/j.urolonc.2011.09.004.
    Full Text Link to Item
  - He, Wei, Xuesong Li, Shuping Xu, Junkui Ai, Yanqing Gong, Jennifer L. Gregg, Ruili Guan, et al. “Aberrant methylation and loss of CADM2 tumor suppressor expression is associated with human renal cell carcinoma tumor progression.” Biochem Biophys Res Commun 435, no. 4 (June 14, 2013): 526–32. https://doi.org/10.1016/j.bbrc.2013.04.074.
    Full Text Link to Item
  - Knowles, Lynn M., James Zewe, Gunjan Malik, Anil V. Parwani, Jeffrey R. Gingrich, and Jan Pilch. “CLT1 targets bladder cancer through integrin α5β1 and CLIC3.” Mol Cancer Res 11, no. 2 (February 2013): 194–203. https://doi.org/10.1158/1541-7786.MCR-12-0300.
    Full Text Link to Item
  - Wilt, Timothy J., Michael K. Brawer, Karen M. Jones, Michael J. Barry, William J. Aronson, Steven Fox, Jeffrey R. Gingrich, et al. “Radical prostatectomy versus observation for localized prostate cancer.” N Engl J Med 367, no. 3 (July 19, 2012): 203–13. https://doi.org/10.1056/NEJMoa1113162.
    Full Text Link to Item
  - Armstrong, A. J., J. R. Gingrich, M. Haggman, W. M. Stadler, J. E. Damber, L. Belkoff, R. Clark, et al. “Long term safety and efficacy in a randomized multicenter international phase II study of tasquinimod in chemotherapy naive patients with metastatic castrate-resistant prostate cancer.” European Urology Supplements 11, no. 1 (February 1, 2012): E126-U515.
    Link to Item
  - Pili, Roberto, Michael Häggman, Walter M. Stadler, Jeffrey R. Gingrich, Vasileios J. Assikis, Anders Björk, Orjan Nordle, Goran Forsberg, Michael A. Carducci, and Andrew J. Armstrong. “Phase II randomized, double-blind, placebo-controlled study of tasquinimod in men with minimally symptomatic metastatic castrate-resistant prostate cancer.” J Clin Oncol 29, no. 30 (October 20, 2011): 4022–28. https://doi.org/10.1200/JCO.2011.35.6295.
    Full Text Link to Item
  - Chen, Li, Bin Fang, Francesco Giorgianni, Jeffrey R. Gingrich, and Sarka Beranova-Giorgianni. “Investigation of phosphoprotein signatures of archived prostate cancer tissue specimens via proteomic analysis.” Electrophoresis 32, no. 15 (August 2011): 1984–91. https://doi.org/10.1002/elps.201100101.
    Full Text Link to Item
  - Gingrich, Jeffrey R. “Bladder cancer: chemohyperthermia for bladder cancer--clinically effective?” Nat Rev Urol 8, no. 8 (July 19, 2011): 414–16. https://doi.org/10.1038/nrurol.2011.104.
    Full Text Link to Item
  - Armstrong, A. J., M. Haggman, W. M. Stadler, J. R. Gingrich, V. J. Assikis, O. Nordle, G. Forsberg, M. A. Carducci, and R. Pili. “Phase II study of tasquinimod in chemotherapy-naive patients with metastatic castrate-resistant prostate cancer (CRPC): Safety and efficacy analysis including subgroups.” Journal of Clinical Oncology 29, no. 7_suppl (March 1, 2011): 126–126. https://doi.org/10.1200/jco.2011.29.7_suppl.126.
    Full Text
  - Armstrong, A. J., M. Haggman, W. M. Stadler, J. R. Gingrich, V. J. Assikis, O. Nordle, G. Forsberg, M. A. Carducci, and R. Pili. “Phase II study of tasquinimod in chemotherapy-naive patients with metastatic castrate-resistant prostate cancer (CRPC): Safety and efficacy analysis including subgroups.” J Clin Oncol 29, no. 7_suppl (March 2011): 126.
    Link to Item
  - Chang, Guimin, Shuping Xu, Rajiv Dhir, Uma Chandran, Denise S. O’Keefe, Norman M. Greenberg, and Jeffrey R. Gingrich. “Hypoexpression and epigenetic regulation of candidate tumor suppressor gene CADM-2 in human prostate cancer.” Clin Cancer Res 16, no. 22 (November 15, 2010): 5390–5401. https://doi.org/10.1158/1078-0432.CCR-10-1461.
    Full Text Link to Item
  - Corcoran, Anthony T., and Jeffrey R. Gingrich. “Hyperthermia and intravesical therapy: emerging one-two punch for bladder cancer?” Oncology (Williston Park) 24, no. 12 (November 15, 2010): 1161–66.
    Link to Item
  - Smaldone, M. C., and J. R. Gingrich. “Immunotherapeutic agents for the management of BCG refractory non-muscle invasive bladder cancer.” Minerva Urol Nefrol 62, no. 2 (June 2010): 129–32.
    Link to Item
  - Pili, R., M. Haggman, W. M. Stadler, J. R. Gingrich, V. J. Assikis, A. Bjork, G. Forsberg, M. A. Carducci, and A. J. Armstrong. “A randomized, multicenter, international phase II study of tasquinimod in chemotherapy naive patients with metastatic castrate-resistant prostate cancer (CRPC).” Journal of Clinical Oncology 28, no. 15 (May 20, 2010).
    Link to Item
  - Chang, Guimin, Shuping Xu, Makiko Watanabe, Himangi R. Jayakar, Michael A. Whitt, and Jeffrey R. Gingrich. “Enhanced oncolytic activity of vesicular stomatitis virus encoding SV5-F protein against prostate cancer.” J Urol 183, no. 4 (April 2010): 1611–18. https://doi.org/10.1016/j.juro.2009.12.005.
    Full Text Link to Item
  - Smaldone, Marc C., Daniel P. Casella, Daniel R. Welchons, and Jeffrey R. Gingrich. “Investigational therapies for non-muscle invasive bladder cancer.” Expert Opin Investig Drugs 19, no. 3 (March 2010): 371–83. https://doi.org/10.1517/13543780903563372.
    Full Text Link to Item
  - Smaldone, M. C., B. A. Gayed, J. J. Tomaszewski, and J. R. Gingrich. “Strategies to enhance the efficacy of intravescical therapy for non-muscle invasive bladder cancer.” Minerva Urol Nefrol 61, no. 2 (June 2009): 71–89.
    Link to Item
  - Wilt, Timothy J., Michael K. Brawer, Michael J. Barry, Karen M. Jones, Young Kwon, Jeffrey R. Gingrich, William J. Aronson, et al. “The Prostate cancer Intervention Versus Observation Trial:VA/NCI/AHRQ Cooperative Studies Program #407 (PIVOT): design and baseline results of a randomized controlled trial comparing radical prostatectomy to watchful waiting for men with clinically localized prostate cancer.” Contemp Clin Trials 30, no. 1 (January 2009): 81–87. https://doi.org/10.1016/j.cct.2008.08.002.
    Full Text Link to Item
  - Chikwava, Kudakwashe R., Jeffrey R. Gingrich, and Anil V. Parwani. “Lymphoepithelioma-like carcinoma of the urinary bladder.” Pathology 40, no. 3 (April 2008): 310–11. https://doi.org/10.1080/00313020701813636.
    Full Text Link to Item
  - Xiao, W., Q. Zhang, G. Habermacher, X. Yang, A. -. Y. Zhang, X. Cai, J. Hahn, et al. “U19/Eaf2 knockout causes lung adenocarcinoma, B-cell lymphoma, hepatocellular carcinoma and prostatic intraepithelial neoplasia.” Oncogene 27, no. 11 (March 6, 2008): 1536–44. https://doi.org/10.1038/sj.onc.1210786.
    Full Text Link to Item
  - Hernandez, Inmaculada, Lisette A. Maddison, Yongli Wei, Francesco DeMayo, Tobias Petras, Baolin Li, Jeffrey R. Gingrich, Jeffrey M. Rosen, and Norman M. Greenberg. “Prostate-specific expression of p53(R172L) differentially regulates p21, Bax, and mdm2 to inhibit prostate cancer progression and prolong survival.” Mol Cancer Res 1, no. 14 (December 2003): 1036–47.
    Link to Item
  - Hale, G. A., R. J. Rochester, H. E. Heslop, R. A. Krance, J. R. Gingrich, E. Benaim, E. M. Horwitz, et al. “Hemorrhagic cystitis after allogeneic bone marrow transplantation in children: clinical characteristics and outcome.” Biol Blood Marrow Transplant 9, no. 11 (November 2003): 698–705. https://doi.org/10.1016/s1083-8791(03)00269-6.
    Full Text Link to Item
  - Foster, Barbara A., Andreas Evangelou, J. R. Gingrich, Paula J. Kaplan, Franco DeMayo, and Norman M. Greenberg. “Enforced expression of FGF-7 promotes epithelial hyperplasia whereas a dominant negative FGFR2iiib promotes the emergence of neuroendocrine phenotype in prostate glands of transgenic mice.” Differentiation 70, no. 9–10 (December 2002): 624–32. https://doi.org/10.1046/j.1432-0436.2002.700915.x.
    Full Text Link to Item
  - Lin, Xu, Jeffrey R. Gingrich, Wenjun Bao, Jie Li, Zishan A. Haroon, and Wendy Demark-Wahnefried. “Effect of flaxseed supplementation on prostatic carcinoma in transgenic mice.” Urology 60, no. 5 (November 2002): 919–24. https://doi.org/10.1016/s0090-4295(02)01863-0.
    Full Text Link to Item
  - Steiner, Mitchell S., Jeffrey R. Gingrich, and Ravi D. Chauhan. “Prostate cancer gene therapy.” Surg Oncol Clin N Am 11, no. 3 (July 2002): 607–20. https://doi.org/10.1016/s1055-3207(02)00026-1.
    Full Text Link to Item
  - Weld, Kyle J., Brant E. Mayher, James A. Allay, Jody L. Cockroft, Christopher P. Reed, Mildred M. Randolph, Yi Lu, Mitchell S. Steiner, and Jeffrey R. Gingrich. “Transrectal gene therapy of the prostate in the canine model.” Cancer Gene Ther 9, no. 2 (February 2002): 189–96. https://doi.org/10.1038/sj.cgt.7700425.
    Full Text Link to Item
  - Blankenship, J. C., M. L. Gavant, C. E. Cox, R. D. Chauhan, and J. R. Gingrich. “Importance of delayed imaging for blunt renal trauma.” World J Surg 25, no. 12 (December 2001): 1561–64. https://doi.org/10.1007/s00268-001-0150-0.
    Full Text Link to Item
  - Gingrich, J. R., R. D. Chauhan, and M. S. Steiner. “Gene therapy for prostate cancer.” Curr Oncol Rep 3, no. 5 (September 2001): 438–47. https://doi.org/10.1007/s11912-001-0031-6.
    Full Text Link to Item
  - CHAUHAN, RAVI D., JEFFREY R. GINGRICH, M. A. H. M. O. U. D. ELTORKY, and MITCHELL S. STEINER. “THE NATURAL PROGRESSION OF ADENOCARCINOMA OF THE EPIDIDYMIS.” The Journal of Urology, August 2001, 608–10. https://doi.org/10.1097/00005392-200108000-00048.
    Full Text
  - Chauhan, R. D., J. R. Gingrich, M. Eltorky, and M. S. Steiner. “The natural progression of adenocarcinoma of the epididymis.” J Urol 166, no. 2 (August 2001): 608–10.
    Link to Item
  - Gingrich, J. R., R. D. Chauhan, and M. S. Steiner. “Gene therapy for prostate cancer.” Curr Urol Rep 2, no. 3 (June 2001): 199–208. https://doi.org/10.1007/s11934-001-0079-8.
    Full Text Link to Item
  - Mayher, B. E., J. L. Guyton, and J. R. Gingrich. “Impact of urethral injury management on the treatment and outcome of concurrent pelvic fractures.” Urology 57, no. 3 (March 2001): 439–42. https://doi.org/10.1016/s0090-4295(00)01038-4.
    Full Text Link to Item
  - Bruckheimer, E. M., S. Brisbay, D. J. Johnson, J. R. Gingrich, N. Greenberg, and T. J. McDonnell. “Bcl-2 accelerates multistep prostate carcinogenesis in vivo.” Oncogene 19, no. 46 (November 2, 2000): 5251–58. https://doi.org/10.1038/sj.onc.1203881.
    Full Text Link to Item
  - STEINER, MITCHELL S., and JEFFREY R. GINGRICH. “GENE THERAPY FOR PROSTATE CANCER: WHERE ARE WE NOW?” The Journal of Urology, October 2000, 1121–36. https://doi.org/10.1097/00005392-200010000-00002.
    Full Text
  - Steiner, M. S., and J. R. Gingrich. “Gene therapy for prostate cancer: where are we now?” J Urol 164, no. 4 (October 2000): 1121–36.
    Link to Item
  - Bruckheimer, E. M., S. Cho, S. Brisbay, D. J. Johnson, J. R. Gingrich, N. Greenberg, and T. J. McDonnell. “The impact of bcl-2 expression and bax deficiency on prostate homeostasis in vivo.” Oncogene 19, no. 20 (May 11, 2000): 2404–12. https://doi.org/10.1038/sj.onc.1203571.
    Full Text Link to Item
  - Gingrich, J. R., and M. S. Steiner. “Gene therapy in urologic oncology.” World J Urol 18, no. 2 (April 2000): 91–92. https://doi.org/10.1007/s003450050179.
    Full Text Link to Item
  - Strong, C., J. R. Gingrich, and W. H. Kutteh. “Ethics of postmortem sperm retrieval: ethics of sperm retrieval after death or persistent vegetative state.” Hum Reprod 15, no. 4 (April 2000): 739–45. https://doi.org/10.1093/humrep/15.4.739.
    Full Text Link to Item
  - McCarville, M. B., F. A. Hoffer, J. R. Gingrich, and J. J. Jenkins. “Imaging findings of hemorrhagic cystitis in pediatric oncology patients.” Pediatr Radiol 30, no. 3 (March 2000): 131–38. https://doi.org/10.1007/s002470050031.
    Full Text Link to Item
  - Gingrich, J. R. “Erratum: C-CAM adhesion in mouse model (Journal of Urology 162:3 (892)).” Journal of Urology 163, no. 1 (January 1, 2000): 253.
  - Gingrich, J. R. “C-CAM adhesion in mouse model (vol 162, pg 892, 1999).” Journal of Urology 163, no. 1 (January 1, 2000): 253–253.
    Link to Item
  - Gingrich, J. R., R. J. Barrios, B. A. Foster, and N. M. Greenberg. “Pathologic progression of autochthonous prostate cancer in the TRAMP model.” Prostate Cancer Prostatic Dis 2, no. 2 (March 1999): 70–75. https://doi.org/10.1038/sj.pcan.4500296.
    Full Text Link to Item
  - Gingrich, J. R., and M. S. Steiner. “A gene hunting we will go!.” Urol Res 26, no. 6 (1998): 361–69. https://doi.org/10.1007/s002400050070.
    Full Text Link to Item
  - Gingrich, J. R., R. J. Barrios, M. W. Kattan, H. S. Nahm, M. J. Finegold, and N. M. Greenberg. “Androgen-independent prostate cancer progression in the TRAMP model.” Cancer Res 57, no. 21 (November 1, 1997): 4687–91.
    Link to Item
  - Foster, B. A., J. R. Gingrich, E. D. Kwon, C. Madias, and N. M. Greenberg. “Characterization of prostatic epithelial cell lines derived from transgenic adenocarcinoma of the mouse prostate (TRAMP) model.” Cancer Res 57, no. 16 (August 15, 1997): 3325–30.
    Link to Item
  - Gingrich, J. R., R. J. Barrios, R. A. Morton, B. F. Boyce, F. J. DeMayo, M. J. Finegold, R. Angelopoulou, J. M. Rosen, and N. M. Greenberg. “Metastatic prostate cancer in a transgenic mouse.” Cancer Res 56, no. 18 (September 15, 1996): 4096–4102.
    Link to Item
  - Gingrich, J. R., and N. M. Greenberg. “A transgenic mouse prostate cancer model.” Toxicol Pathol 24, no. 4 (July 1996): 502–4. https://doi.org/10.1177/019262339602400414.
    Full Text Link to Item
  - Gingrich, J. R., and D. F. Paulson. “The impact of PSA on prostate cancer management. Can we abandon routine staging pelvic lymphadenectomy?” Surg Oncol Clin N Am 4, no. 2 (April 1995): 335–44.
    Link to Item
  - Keane, T. E., J. R. Gingrich, G. Rosner, K. S. Webb, S. H. Poulton, and P. J. Walther. “Combination versus single agent therapy in effecting complete therapeutic response in human bladder cancer: analysis of cisplatin and/or 5-fluorouracil in an in vivo survival model.” Cancer Res 54, no. 2 (January 15, 1994): 475–81.
    Link to Item
  - Keane, T. E., G. L. Rosner, J. R. Gingrich, S. H. Poulton, and P. J. Walther. “The therapeutic impact of dipyridamole: chemopotentiation of the cytotoxic combination 5-fluorouracil/cisplatin in an animal model of human bladder cancer.” J Urol 146, no. 5 (November 1991): 1418–24. https://doi.org/10.1016/s0022-5347(17)38127-2.
    Full Text Link to Item
  - Gingrich, J. R., J. A. Tucker, P. J. Walther, J. W. Day, S. H. Poulton, and K. S. Webb. “Establishment and characterization of a new human prostatic carcinoma cell line (DuPro-1).” J Urol 146, no. 3 (September 1991): 915–19. https://doi.org/10.1016/s0022-5347(17)37960-0.
    Full Text Link to Item
  - Keane, T. E., J. R. Gingrich, G. Rosner, and P. J. Walther. “Preclinical in vivo assessment of 5-fluorouracil/cisplatin with and without dipyridamole against a human bladder tumor line: Correlation of tumor growth inhibition with host survival.” Surgical Forum 41 (December 1, 1990): 696–98.
- Conference Papers
  - Carducci, M., A. Armstrong, M. Haggman, W. M. Stadler, J. R. Gingrich, V. Assikis, G. Forsberg, A. Olsson, O. Nordle, and R. Pili. “TASQUINIMOD MECHANISM OF ACTION BIOMARKERS: CORRELATION WITH PFS AND SURVIVAL IN MEN WITH METASTATIC CASTRATE RESISTANT PROSTATE CANCER TREATED IN A RANDOMIZED PHASE 2 TRIAL.” In Annals of Oncology, 23:303–303. OXFORD UNIV PRESS, 2012.
    Link to Item
  - Armstrong, Andrew J., Michael Haggman, Walter Michael Stadler, Jeffrey R. Gingrich, Vasily J. Assikis, Jonathan Polikoff, Samuel R. Denmeade, et al. “Tasquinimod and survival in men with metastatic castration-resistant prostate cancer: Results of long-term follow-up of a randomized phase II placebo-controlled trial.” In Journal of Clinical Oncology, Vol. 30. AMER SOC CLINICAL ONCOLOGY, 2012.
    Link to Item
  - Giorgianni, F., J. R. Gingrich, M. S. Steiner, D. M. Desiderio, and S. Beranova-Giorgianni. “Analysis of the proteome in the human prostate.” In Proceedings 50th Asms Conference on Mass Spectrometry and Allied Topics, 281–82, 2002.
Scholarly, Clinical, & Service Activities
Academic & Administrative Activities
- Chief of Urology at the Durham VA Health Care System.

Some information on this profile has been compiled automatically from Duke databases and external sources. (Our About page explains how this works.) If you see a problem with the information, please write to Scholars@Duke and let us know. We will reply promptly.

Education, Training, & Certifications

Medical Licensure

Duke Appointment History

Academic Positions Outside Duke

Selected Publications

Academic Articles

Conference Papers

Academic & Administrative Activities